Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Expensive Performer
260.2300 5.14 (2.01%)
NSE Jul 10, 2026 15:31 PM
Volume: 366.1K
 

260.23
2.01%
ICICI Securities Limited
Formulation exports accounted for 40% (regulated markets:81%) of revenues while APIs contributed 8% with remaining coming from CRAMS Q3FY22 Results: Indoco reported revenue growth due to traction in domestic...
Indoco Remedies has gained 28.57% in the last 3 Months
More from Indoco Remedies Ltd.
Recommended